Navigate Up
Sign In


The module 1.4.1
MSD abides by Medicines Australia’s Code of Conduct and the Therapeutic Goods Act.
The module 1.5.1

​​Both prohibit a pharmaceutical company from direct to consumer advertising which includes issuing public press statements about our prescription medicines. We are able to issue public statements to advise registration of a new medicine, a reimbursement notice of a new medicine or any general corporate news not related to our medicines. For any specific issues please contact the communications manager
The module 1.5.2
The module 1.5.3
The module 1.5.1

The module 1.5.1

The module 1.4.3
The module 1.4.3 with Left image
The module 1.4.4
The module 1.4.7/1.4.8
The module 1.6.*


Tanya Holloway
Communications Manager
Phone: +61 407 695 885​​

The module 1.6.*

The module 1.6.*

  • This site is intended for Australian residents. MSD is a member of Medicines Australia. MSD recommends patients always seek the medical advice of their healthcare professional.